MR

Mark Ragosa

DELAYED 1 MONTH

CHIEF FINANCIAL OFFICER

Kiniksa Pharmaceuticals International, plc

Filings

1

Companies

1

Latest

Mar 9, 2026

Transactions

Signal

Ticker / Company

Insider

Transaction

Value

Filed

74
KNSACLUSTER 275% OUT

Kiniksa Pharmaceuticals International, plc

Mark Ragosa

CHIEF FINANCIAL OFFICER

Sale

$1.7M

36,722 sh

Mar 11 8:38 PM

Mar 9, 2026

—

Kiniksa Pharmaceuticals International, plc

Mark Ragosa

CHIEF FINANCIAL OFFICER

Option Exercise

$759.8K

36,722 sh

Mar 11 8:38 PM

Mar 9, 2026